Home - Products - Angiogenesis - EGFR - Sodium Nitroprusside Dihydrate

Sodium Nitroprusside Dihydrate

CAS No. 13755-38-9

Sodium Nitroprusside Dihydrate( Sodium nitroprusside dihydrate | Sodium Nitroferricyanide(III) Dihydrate )

Catalog No. M17986 CAS No. 13755-38-9

Sodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 41 In Stock
1G 42 In Stock

Biological Information

  • Product Name
    Sodium Nitroprusside Dihydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.
  • Description
    Sodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.(In Vitro):Nitroprusside disodium dehydrate sensitizes human gastric cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
  • In Vitro
    Nitroprusside disodium dehydrate sensitizes human gastric cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
  • In Vivo
    ——
  • Synonyms
    Sodium nitroprusside dihydrate | Sodium Nitroferricyanide(III) Dihydrate
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    guanylate cyclase
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    13755-38-9
  • Formula Weight
    297.95
  • Molecular Formula
    C5H4FeN6Na2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 46 mg/mL; 154.39 mM
  • SMILES
    [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Befotertinib

    Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.

  • Canertinib dihydroch...

    A potent, irreversible, orally available pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 7.5 nM and 9.0 nM in autophosphorylation assay.

  • EGFR-IN-7

    EGFR-IN-7 is a selective and potent EGFR kinase inhibitor.TQB3804 displayed potent enzymatic activities for EGFRd746-750/T790M/C797S, EGFRL858R/T790M/C797S, EGFRd746-750/T790M, and EGFRL858R/T790M with IC50 of 0.46, 0.13, 0.26, and 0.19 nM respectively, and has similar enzymatic activity for EGFRWT (IC50 = 1.07) to Osimertinib.